GO:0002414 immunoglobulin transcytosis in epithelial cells: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002414 describes the transport of immunoglobulin across an epithelial cell from one side to the other via transcytosis.
• The polymeric immunoglobulin receptor (pIgR) is the canonical receptor that binds dimeric IgA and pentameric IgM and carries them across mucosal epithelia.
• Transcytosis is a vesicular transport process that can be exploited for drug delivery, including antibody transport across the blood-brain barrier and respiratory epithelium.
• Receptor affinity and valency strongly influence transcytosis efficiency and targeting specificity.
• pIgR and immunoglobulin transcytosis are implicated in mucosal immunity and in lung injury during severe bacterial pneumonia.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of transcytosis genes in epithelial cells.
Description
Immunoglobulin transcytosis in epithelial cells (GO:0002414) is the biological process by which immunoglobulin molecules are transported from one side of an epithelial cell to the other via transcytosis. This process is central to mucosal immunity, as it allows antibodies produced in the lamina propria to reach mucosal surfaces and secretions. The polymeric immunoglobulin receptor (pIgR) mediates the transcytosis of dimeric IgA and pentameric IgM across epithelial barriers, a mechanism conserved in mucosal tissues such as the airway, gut, and salivary glands. Beyond its physiological role, immunoglobulin transcytosis is a target for therapeutic antibody engineering, including strategies to enhance brain uptake or deliver antibodies across epithelial barriers. Researchers study GO:0002414 to understand how antibodies are moved across cellular barriers, how pathogens exploit or are neutralized by this transport, and how to engineer antibodies or nanocarriers for improved delivery. The process is also relevant to disease: plasma polymeric immunoglobulin receptor has been linked to exacerbated lung injury in Klebsiella pneumoniae-induced pneumosepsis. Because transcytosis involves vesicular trafficking, its molecular dissection overlaps with general mechanisms of transcellular vesicular transport in epithelial and endothelial cells. This article provides a research-grade overview of GO:0002414, covering its definition, mechanism, key genes, disease relevance, and experimental methods, with a focus on how CRISPR-based models can be used to interrogate this process.
immunoglobulin transcytosis in epithelial cells At A Glance
| GO ID | GO:0002414 |
|---|---|
| GO term | immunoglobulin transcytosis in epithelial cells |
| Ontology | biological_process |
| Synonym | None |
| Definition | The process of transporting immunoglobulin, via transcytosis, from one side of an epithelial cell to the other. |
| Major function | Transcellular transport of immunoglobulins across epithelial barriers |
| Key receptor | Polymeric immunoglobulin receptor (pIgR) for IgA and IgM |
| Related process | Transcellular vesicular transport in epithelial and endothelial cells |
| Therapeutic relevance | Antibody delivery across epithelial and endothelial barriers |
What Is GO:0002414?
GO:0002414, immunoglobulin transcytosis in epithelial cells, is defined as the process of transporting immunoglobulin, via transcytosis, from one side of an epithelial cell to the other. In practice, this involves receptor-mediated binding of immunoglobulin at one membrane domain, vesicular internalization, transport across the cell, and release at the opposite membrane domain.
Why Is immunoglobulin transcytosis in epithelial cells Important in Cell Biology?
GO:0002414 is important because it governs how immunoglobulins are moved across epithelial barriers, a process essential for mucosal immunity and for the rational design of antibody-based therapeutics. Understanding this process helps explain how secretory IgA and IgM are delivered to mucosal surfaces, how pathogens such as Klebsiella pneumoniae interact with pIgR, and how engineered antibodies can be optimized for transcytosis across the blood-brain barrier or respiratory epithelium.
• Enables secretion of dimeric IgA and pentameric IgM across mucosal epithelia via pIgR.
• Supports mucosal immune defense in the respiratory, gastrointestinal, and salivary systems.
• Provides a mechanism for therapeutic antibody delivery across epithelial and endothelial barriers.
• Is exploited in brain-targeted antibody engineering by modulating receptor affinity.
• Is linked to lung injury in Klebsiella pneumoniae-induced pneumosepsis through plasma pIgR.
• Shares core machinery with general transcellular vesicular transport pathways.
• Can be targeted by nanobody-functionalized carriers for cell-specific mRNA delivery.
• Serves as a model for studying receptor-mediated transcytosis and intracellular sorting.
What Happens During immunoglobulin transcytosis in epithelial cells?
Receptor binding at the basolateral surface
In simple terms: An antibody binds to a receptor on one side of the cell.
In the canonical pathway, polymeric immunoglobulin receptor (pIgR) on the basolateral surface of epithelial cells binds dimeric IgA or pentameric IgM. This receptor-ligand interaction initiates the transcytosis process and determines the specificity of immunoglobulin transport.
Vesicular internalization and transcellular transport
In simple terms: The cell engulfs the antibody-receptor complex and moves it across the cell.
Following binding, the immunoglobulin-receptor complex is internalized into vesicles and transported across the epithelial cell. This step relies on general transcellular vesicular transport machinery shared with endothelial cells.
Release at the apical surface
In simple terms: The antibody is released on the other side of the cell.
The transported immunoglobulin is released at the apical surface, where it can participate in mucosal defense. For pIgR, cleavage can release the extracellular domain as secretory component bound to IgA.
Regulation by receptor affinity and valency
In simple terms: How tightly the antibody binds affects how well it is transported.
Modulating antibody affinity for transcytosis receptors can enhance or reduce transport efficiency. High-affinity brain-selective VNAR antibodies targeting transferrin receptor 1 demonstrate that receptor engagement properties are critical for transcytosis.
Exploitation for therapeutic delivery
In simple terms: Scientists use this transport system to deliver drugs.
Antibody transcytosis and neutralizing activity have been studied in respiratory epithelial cells for therapeutic applications. Nanobody-functionalized lipid nanoparticles can achieve cell-specific mRNA delivery, illustrating how transcytosis-related targeting can be engineered.
Key Genes Involved in GO:0002414 immunoglobulin transcytosis in epithelial cells
The following genes and proteins are central to immunoglobulin transcytosis in epithelial cells, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIGR | Binds dimeric IgA and pentameric IgM for transcytosis across epithelia | Canonical receptor for GO:0002414; target for mucosal immunity studies |
| TFRC | Transferrin receptor 1 mediates transcytosis of antibodies across the blood-brain barrier | Model receptor for engineering antibody transcytosis |
| FCGRT | Neonatal Fc receptor involved in immunoglobulin transport and half-life | Relevant to antibody pharmacokinetics and transcytosis |
| IGHA1 | Heavy chain of IgA, a substrate for pIgR-mediated transcytosis | Ligand for studying pIgR-dependent transport |
| IGHM | Heavy chain of IgM, a substrate for pIgR-mediated transcytosis | Ligand for studying pIgR-dependent transport |
| JCHAIN | Joining chain required for dimeric IgA and pentameric IgM formation | Essential for ligand assembly and pIgR binding |
| RAB11A | Regulates vesicular trafficking in transcytosis pathways | Candidate for mechanistic studies of transcytosis |
| RAB25 | Associated with apical recycling and epithelial transport | Potential regulator of transcytosis |
| RAB17 | Implicated in transcytosis in epithelial cells | Model gene for vesicle trafficking |
| ARF6 | Regulates membrane trafficking and endosomal recycling | Candidate for transcytosis regulation |
| EEA1 | Early endosome marker involved in endocytic sorting | Used to track transcytosis vesicles |
| VAMP3 | SNARE protein involved in vesicular transport | Potential mediator of transcytosis fusion events |
| STX4 | Syntaxin involved in vesicle fusion at membranes | Candidate for transcytosis regulation |
| SNAP23 | SNARE protein participating in vesicle fusion | Relevant to transcytosis membrane fusion |
| CLTC | Clathrin heavy chain involved in endocytosis | Potential role in receptor internalization |
| AP2M1 | Adaptor protein for clathrin-mediated endocytosis | Candidate for transcytosis initiation |
| DNM2 | Dynamin 2 mediates vesicle scission | Potential role in transcytosis vesicle formation |
| ACTB | Actin cytoskeleton supports vesicle transport | Structural support for transcytosis |
How Is immunoglobulin transcytosis in epithelial cells Regulated?
Regulation of immunoglobulin transcytosis in epithelial cells involves receptor affinity, valency, and vesicular trafficking machinery. Modulating antibody affinity for transcytosis targets can enhance brain uptake, as shown for transferrin receptor-targeting antibodies. High-affinity brain-selective VNAR antibodies targeting transferrin receptor 1 further demonstrate that receptor engagement properties regulate transcytosis efficiency. General transcellular vesicular transport pathways, including Rab and SNARE proteins, provide the regulatory framework for this process.
immunoglobulin transcytosis in epithelial cells and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGR | Klebsiella pneumoniae-induced pneumosepsis | pIgR knockout epithelial cells and lung infection models |
| TFRC | Blood-brain barrier transport for neurodegeneration | TfR1 knock-in mice and brain endothelial cells |
| IGHA1 | Mucosal immunity and IgA deficiency | IgA knockout epithelial cell models |
| IGHM | Mucosal immunity and IgM deficiency | IgM knockout epithelial cell models |
| JCHAIN | IgA/IgM polymerization and mucosal defense | JCHAIN knockout epithelial cells |
Mucosal immunity and infection
pIgR-mediated transcytosis is critical for mucosal immunity, and plasma polymeric immunoglobulin receptor exacerbates lung injury in Klebsiella pneumoniae-induced pneumosepsis. This highlights the dual role of transcytosis components in host defense and pathology.
Respiratory epithelial antibody transport
Antibody transcytosis and neutralizing activity in respiratory epithelial cells are relevant to therapeutic antibody design and respiratory infections. Understanding this process can inform treatments for airway diseases.
Blood-brain barrier and neurodegeneration
Transcytosis across the blood-brain barrier is a major challenge for therapeutic antibodies, and reducing affinity for a transcytosis target can boost brain uptake. Novel blood-brain barrier targets have been discovered to enhance brain uptake of therapeutic antibodies.
Targeted delivery and nanomedicine
Cell-specific mRNA delivery via nanobody-functionalized lipid nanoparticles demonstrates how transcytosis-related targeting can be harnessed for therapeutic delivery. This approach may improve precision in epithelial and endothelial targeting.
From immunoglobulin transcytosis in epithelial cells-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PIGR mediate IgA transcytosis in airway epithelium? | PIGR knockout epithelial cell line |
| Does a point mutation in TFRC alter antibody transcytosis? | TFRC point-mutation knock-in cells |
| Can a tagged pIgR be used to track transcytosis? | Tagged knock-in of PIGR |
| Does overexpression of RAB11A enhance transcytosis? | RAB11A overexpression epithelial cells |
| Which genes regulate transcytosis in epithelial cells? | CRISPR library screening in epithelial cells |
| Does JCHAIN knockout affect IgA secretion? | JCHAIN knockout epithelial cells |
How to Study the immunoglobulin transcytosis in epithelial cells Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on transcytosis | Testing PIGR or TFRC requirement |
| Knock-in tagging | Receptor localization and trafficking | Tracking pIgR or TfR1 in live cells |
| Transcytosis assay | Immunoglobulin transport across epithelial monolayers | Measuring IgA or IgG transport |
| Live-cell imaging | Vesicle dynamics and receptor movement | Visualizing transcytosis pathways |
| CRISPR library screening | Identification of transcytosis regulators | Genome-wide screens in epithelial cells |
| Bioinformatics pathway analysis | Enrichment of trafficking genes | Prioritizing candidate regulators |
| Antibody neutralization assay | Functional activity after transcytosis | Respiratory epithelial cell studies |
CRISPR knockout and knock-in models
CRISPR knockout of PIGR, TFRC, or trafficking genes can test their requirement for immunoglobulin transcytosis. Knock-in of tagged receptors enables visualization and quantification of transport.
Imaging and vesicle tracking
Fluorescence imaging of transcytosis vesicles and receptor trafficking can reveal the route of immunoglobulin transport across epithelial cells. Live-cell imaging of tagged receptors supports dynamic studies.
Antibody transport assays
Transcytosis assays using polarized epithelial cells measure immunoglobulin transport from basolateral to apical compartments. Neutralizing activity can be assessed in respiratory epithelial cells.
Library screening and bioinformatics
CRISPR library screening can identify regulators of transcytosis in epithelial cells. Bioinformatics analysis of trafficking pathways can prioritize candidate genes for follow-up.
How CRISPR Can Be Used to Study GO:0002414 immunoglobulin transcytosis in epithelial cells
Knockout
CRISPR knockout of PIGR, TFRC, or vesicle trafficking genes can determine whether they are required for immunoglobulin transcytosis in epithelial cells. Loss-of-function models help establish causal roles in transport.
Point Mutation
Point mutations in receptor genes such as TFRC can be introduced to test how specific residues affect antibody transcytosis and affinity. This approach refines structure-function understanding.
Knock-in
Knock-in of tagged PIGR or TFRC allows tracking of receptor localization and transport in polarized epithelial cells. Tagged knock-in models support imaging-based transcytosis studies.
Overexpression
Overexpression of trafficking regulators such as RAB11A or RAB25 can test whether increased levels enhance transcytosis. Overexpression models complement loss-of-function studies.
How EDITGENE Supports immunoglobulin transcytosis in epithelial cells Research
Researchers studying immunoglobulin transcytosis in epithelial cells-related genes often need to determine whether a candidate gene is causally involved in transport, whether a specific mutation alters receptor function, or whether overexpression enhances transcytosis. EDITGENE provides CRISPR-based cell model services to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for immunoglobulin transcytosis in epithelial cells research.
Frequently Asked Questions About immunoglobulin transcytosis in epithelial cells
What is GO:0002414?
GO:0002414 is the Gene Ontology term for immunoglobulin transcytosis in epithelial cells, defined as the process of transporting immunoglobulin, via transcytosis, from one side of an epithelial cell to the other.
What genes are involved in immunoglobulin transcytosis in epithelial cells?
Key genes include PIGR, which binds IgA and IgM for transcytosis, and TFRC, which mediates antibody transport across the blood-brain barrier.
How does pIgR mediate immunoglobulin transcytosis?
pIgR binds dimeric IgA and pentameric IgM on the basolateral surface and carries them across the epithelial cell for release at the apical surface.
Why is immunoglobulin transcytosis important for mucosal immunity?
It delivers secretory IgA and IgM to mucosal surfaces, providing defense against pathogens.
Can immunoglobulin transcytosis be targeted for drug delivery?
Yes, antibody transcytosis can be engineered for delivery across epithelial and endothelial barriers, including the blood-brain barrier.
What diseases involve defective immunoglobulin transcytosis?
Plasma pIgR has been linked to exacerbated lung injury in Klebsiella pneumoniae-induced pneumosepsis.
How can CRISPR be used to study immunoglobulin transcytosis?
CRISPR knockout, knock-in, and overexpression models can test the role of PIGR, TFRC, and trafficking genes in transcytosis.
What methods measure immunoglobulin transcytosis?
Transcytosis assays, live-cell imaging, and antibody neutralization assays in polarized epithelial cells are commonly used.
What is the role of transferrin receptor in transcytosis?
Transferrin receptor 1 can mediate antibody transcytosis across the blood-brain barrier, and affinity modulation affects brain uptake.
How does EDITGENE support transcytosis research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, and library screening for transcytosis genes.
Conclusion
GO:0002414, immunoglobulin transcytosis in epithelial cells, is a fundamental biological process for mucosal immunity and therapeutic antibody delivery. Its study spans receptor biology, vesicular trafficking, and disease mechanisms, with pIgR and TFRC as central players. CRISPR-based models and screening approaches offer powerful tools to dissect this process and identify new targets for intervention.
References
- 1. Anaya EU et al.. 2026. Antibody Transcytosis and Neutralizing Activity in Respiratory Epithelial Cells.. bioRxiv PMID: 42244684
- 2. Chen L et al.. 2025. Cell-specific mRNA delivery via nanobody-functionalized lipid nanoparticles.. J Control Release 388(Pt 2):114365 PMID: 41161497
- 3. Yu YJ et al.. 2011. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.. Sci Transl Med 3(84):84ra44 PMID: 21613623
- 4. Wang S et al.. 2025. Plasma polymeric immunoglobulin receptor exacerbates lung injury in Klebsiella pneumoniae-induced pneumosepsis.. Front Immunol 16:1624014 PMID: 40642082
- 5. Stocki P et al.. 2021. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1.. FASEB J 35(2):e21172 PMID: 33241587
- 6. Zuchero YJ et al.. 2016. Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies.. Neuron 89(1):70-82 PMID: 26687840
- 7. Fung KYY et al.. 2018. Transcellular vesicular transport in epithelial and endothelial cells: Challenges and opportunities.. Traffic 19(1):5-18 PMID: 28985008
- 8. Asano M et al.. 2011. Polymeric immunoglobulin receptor.. J Oral Sci 53(2):147-56 PMID: 21712618
